Quantum dot/nitroxide-based sensing platform for image-guided drug delivery in cancer
Project/Area Number |
24510321
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Chemical biology
|
Research Institution | National Institute of Radiological Sciences |
Principal Investigator |
RUMIANA Bakalova 独立行政法人放射線医学総合研究所, 分子イメージング研究センター, 主任研究員 (30469936)
|
Co-Investigator(Kenkyū-buntansha) |
AOKI Ichio (ZHELEV Zhivko) 独立行政法人放射線医学総合研究所, 分子イメージング研究センター, チームリーダー (10319519)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2014: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
|
Keywords | Polymersomes / Quantum dots / Nitroxides / Drug delivery systems / Cancer / 量子ドッド / ニトロキシラジカル / DDS / 蛍光イメージング / in vivo イメージング / 腫瘍 / MRI / drug-delivery systems / nanoparticles / polymersomes / quantum dot / nitroxides / fluorescent imaging / EPR imaging / cancer / ニトロキシルラジカル / レドックス / 酸化還元 / 量子ドット / センサー / 蛍光 / 反応性造影剤 |
Outline of Final Research Achievements |
We developed polymersomes, embedding with quantum dots (QDs) and hydrophobic nitroxide-labeled anticancer drug, as a new sensing platform for imaging of drug delivery in cancer. If both substances are retained into the polymersome, there is no fluorescence of QDs. If nitroxide-labeled drug is released from polymersomes, the fluorescence of QDs appeared. On experimental cancer-bearing animals, using optical imaging, we established that these nanoparticles were appropriate for imaging of cancer, lymph node mapping, as well as for imaging of drug delivery. A strong fluorescent signal, corresponding to QD705 fluorescence, was detected in the tumor, as well as into the lymph nodes. The half-life of QD/nitroxide-embeding polymersomes was 6±2 hours in the bloodstream, 8±2 hours into the tumor and 11±3 hours in the lymph nodes. The data suggests these size-controlled long-circulating polymersomes are useful matrix for development of nano-formulations with theranostic capabilities.
|
Report
(4 results)
Research Products
(16 results)
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Tissue redox activity as a sensing platform for imaging of cancer, based on nitroxide redox cycle.2013
Author(s)
2. Bakalova R., Z. Zhelev, I. Aoki, D. Kokuryo,V. Gadjeva, and T. Saga.
Organizer
ISMRM 21st Annual Meeting and Exhibition,
Place of Presentation
Salt Lake, Utah, US,
Related Report
-
[Presentation] Imaging of Tissue redox activity from early to terminal stage of cancer development using nitroxide enhanced MRI.2013
Author(s)
3. Bakalova R., Z. Zhelev, D. Kokuryo,. I. Aoki, V, Gadjeva, and T. Saga.
Organizer
6th World Molecular Imaging Congress,
Place of Presentation
Savannah, Georgia, USA,
Related Report
-
-
-